For patients with cardiovascular disease, kidney disease, and diabetes who also have cost constraints for prescription drugs, what factors most significantly impact your decision to start an SGLT2i OR GLP-1 agonists?

In those with CVD, DM, and CKD, do you prefer SGLT2-i or GLP-1 agonists if they can only afford one of them?

• I generally prefer GLP-1 agonists due to the weight loss benefits
• I generally prefer SGLT1-i given the more impression CV and CKD outcomes
• It depends how far off the patient is from their A1c% goal
• It depends on the degree of albuminuria the patient has
• Other